Innovative Drug Developer Dr. Jeff Geschwind, MD, founded Cage Pharma to target cancer's metabolic engine. His research focuses on disrupting tumor glycolysis, a novel strategy for developing new cancer drugs that aim to stop aggressive cancers in their tracks. https://www.linkedin.com/in/jeff-geschwind-037200174